FIELD: medicine, pharmacy. SUBSTANCE: agent is based on [N-methyl-N-(α, D-glucopyranosyl)ammonium-2-(acridone-9-one- -10-yl)acetate] -cycloferon. Medicinal agent has an active substance and solvent. An active substance is [N-methyl-N-(a, D-glucopyranosyl)ammonium-2-(acridone-9-one- -10-yl)acetate] and solvent - water at the following ratio of components, wt.-%: active substance 18-22.5, and water - the rest. Agent shows low toxicity, high quality and effectiveness and can be used for AIDS treatment, among them HIV-depended. EFFECT: enhanced effectiveness of treatment. 10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT FOR MULTIPLE SCLEROSIS TREATMENT | 1993 |
|
RU2071772C1 |
| MEDICINAL AGENT FOR TUMOR DISEASE TREATMENT | 1993 |
|
RU2076710C1 |
| MEDICINAL AGENT FOR ATHEROSCLEROSIS AND ITS COMPLICATION TREATMENT | 1993 |
|
RU2071768C1 |
| N-METHYL- N- (α-D- GLUCOPYRANOSYL) -AMMONIUM -2-(ACRIDONE -9-ONE -10-YL) -ACETATE (CYCLOFERON) SHOWING INTERFEROGENIC, ANTIVIRAL AMONG THEM ANTI-HIV, ANTIPARASITIC, ANTIPROMOTER AND RADIOPROTECTIVE ACTIVITIES | 1993 |
|
RU2036198C1 |
| SOLID DOSAGED FORM FOR ORAL USING SHOWING ANTIVIRAL ACTIVITY (VARIANTS) | 1995 |
|
RU2115415C1 |
| MEDICINAL PREPARATION FOR PARENTERAL USAGE | 2001 |
|
RU2182004C1 |
| ANTIVIRAL MEDICINAL PREPARATION FOR ORAL USAGE | 2002 |
|
RU2203671C1 |
| IMMUNOSTIMULATING AGENT AND A PREPARATION BASED ON THEREOF | 1995 |
|
RU2120298C1 |
| COMPOSITION COMPRISING LOW-MOLECULAR FRAGMENTS OF PEPTIDOGLICANE OF GRAM-NEGATIVE BACTERIA FOR PREVENTING OR TREATING OF HUMAN DISEASES | 2009 |
|
RU2441906C2 |
| METHOD OF PRODUCING A MEDICINAL PREPARATION FOR PARENTERAL APPLICATION | 2020 |
|
RU2739247C1 |
